Cochrane UK’s Senior Fellow in General Practice Lynda Ware looks at the new Cochrane Reviews are systematic reviews. In systematic reviews we search for and summarize studies that answer a specific research question (e.g. is paracetamol effective and safe for treating back pain?). The studies are identified, assessed, and summarized by using a systematic and predefined approach. They inform recommendations for healthcare and research. on Vitamin D for the management of asthma.
A new Cochrane review looked at precisely this question and found high quality evidence suggesting that it does!
What’s the story?
It seems to me that vitamin D – also known as the ‘sunshine vitamin’ – is very much in the limelight (or should that be sunlight?) right now. Its role in maintaining a healthy skeleton is well known but it may have other important actions. Low levels of vitamin D have been linked to an increased A way of expressing the chance of an event taking place, expressed as the number of events divided by the total number of observations or people. It can be stated as ‘the chance of falling were one in four’ (1/4 = 25%). This measure is good no matter the incidence of events i.e. common or infrequent. of asthma attacks in children and adults with asthma. It is thought that vitamin D has anti-inflammatory and antimicrobial functions in the lungs, which may explain why it could be beneficial.
What is Vitamin D?
Vitamin D is a fat-soluble vitamin. It’s present in a small number of foods such as oily fish, liver, red meat and egg yolks. In the UK, certain foods have vitamin D added to them, for example most margarines, some breakfast cereals and infant formula milk. There are also oral supplements which can be bought over the counter or prescribed by a doctor.
Our main source of vitamin D is from the action of sunlight (the UVB component) on our skin. Certain groups of people are at particular risk of not making enough vitamin D in this way e.g. the frail and housebound, residents of nursing homes, and people who wear clothes that cover up most of their skin. It has been suggested that in the UK it might make sense to take a vitamin D supplement from October to March, when there is insufficient UVB beaming down on us to optimally maintain our levels.
What did the Cochrane review find with regard to vitamin D and asthma?
The recent systematic review from the Cochrane Airways Group found nine double-blind randomized placebo-controlled trials of vitamin D in children and adults with asthma, which evaluated the risk of having an asthma attack and/or the level of symptom control. Two studies were in adults and involved 658 participants; seven studies were in children with 435 participants. The studies were conducted in Canada, India, Japan, Poland, UK and USA. Most of the participants had mild to moderate asthma and continued their regular asthma medication for the duration of the trial. The studies lasted from six to twelve months.
High quality evidence showed that giving vitamin D reduced the average number of asthma attacks and the risk of Emergency Department attendances and hospital admissions. These results can be represented diagrammatically :
There was no evidence to indicate that vitamin D brought about an improvement in lung function tests or in day-to-day symptoms. It was safe at the doses given.
So far so good…..
But why does Adrian Martineau, lead author of the review, advise caution before acting on these results?
Well, a few things remain unanswered…..
It is not clear whether giving vitamin D helps all patients with asthma – or just those who have low vitamin D levels. The majority of participants in the trials had mild to moderate asthma. It’s not certain whether those with more severe disease, and therefore at greater risk of asthma attack, are likely to benefit.
Individual patient data from the trials included in this review are being extracted to see whether benefits are restricted to those with lower vitamin D levels. New Clinical trials are research studies involving people who use healthcare services. They often compare a new or different treatment with the best treatment currently available. This is to test whether the new or different treatment is safe, effective and any better than what is currently used. No matter how promising a new treatment may appear during tests in a laboratory, it must go through clinical trials before its benefits and risks can really be known. in children and adults who are prone to frequent asthma attacks are needed to determine whether vitamin D can prevent asthma attacks in these groups.
The bottom line
Asthma is a common chronic disease affecting about 300 million people worldwide. Despite greater understanding of the disease and its treatment, asthma was responsible for 1216 deaths in UK in 2014 – that’s about 3 people per day.
This systematic review highlights a possible role for vitamin D in preventing severe asthma attacks – cause, I believe, for cautious optimism….
Lynda Ware has nothing to disclose.
Martineau AR, Cates CJ, Urashima M, Jensen M, Griffiths AP, Nurmatov U, Sheikh A, Griffiths CJ. Vitamin D for the management of asthma. Cochrane Database of In systematic reviews we search for and summarize studies that answer a specific research question (e.g. is paracetamol effective and safe for treating back pain?). The studies are identified, assessed, and summarized by using a systematic and predefined approach. They inform recommendations for healthcare and research. 2016, Issue 9. Art. No.: CD011511.pub2.
The Cochrane Library, Wiley Press Room [online]. 2016. High quality evidence suggests Vitamin D can reduce asthma attacks [press release]. 05 September 2016. Available from: http://eu.wiley.com/WileyCDA/PressRelease/pressReleaseId-127902.html